John C. Breneman

Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease

William M. Crist, James R. Anderson, Jane L. Meza et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases

Anthony Mascia, Emily Daugherty, Yongbin Zhang et al. · JAMA Oncology · 2022 · 522 citations · Full text

Irradiated Volume as a Predictor of Brain Radionecrosis After Linear Accelerator Stereotactic Radiosurgery

Brian J. Blonigen, Ryan Steinmetz, Linda Levin et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 489 citations

Adaptive Radiotherapy, Neuro-oncology, Medical Imaging +10

Prognostic Factors and Clinical Outcomes in Children and Adolescents With Metastatic Rhabdomyosarcoma—A Report From the Intergroup Rhabdomyosarcoma Study IV

John C. Breneman, Elizabeth Lyden, Alberto S. Pappo et al. · Journal of Clinical Oncology · 2002 · 466 citations

Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803

Carola A.S. Arndt, Julie A. Stoner, Douglas S. Hawkins et al. · Journal of Clinical Oncology · 2009 · 363 citations · Full text